Shanghai First Biochemical Pharmaceutical

Shanghai First Biochemical Pharmaceutical is a leading Chinese pharmaceutical company specializing in the development and production of biochemical drugs, particularly freeze-dried powder injections and small-volume parenteral solutions. As a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd., the company maintains a dominant position in the domestic market for specialized treatments in hepatology, cardiology, and emergency medicine. Its flagship products include Ademetionine 1,4-butanedisulfonate for injection and various enzyme-based therapies. The company operates large-scale, GMP-certified manufacturing facilities and is recognized for its long history in biochemical extraction and purification technologies.